With the Cancer Immune Atlas in a selected indication, the sophisticated information provided will enable you to improve understanding of a given tumor, through the comprehensive characterization of a representative patients' samples cohort, in order to understand the tumors and immune contextures diversity, and support future diagnostics and treatments developments.
The Cancer Immune Atlas is based on the use of HalioDx proprietary assays & advanced technologies to produce statistically and biologically significant conclusions from large data sets of multiple biomarkers:
The Cancer Immune Atlas allows analysis of single cases and continuous accrual of the data set.